Sansure Biotech Inc (688289) — Financial Flexibility Index
Sansure Biotech Inc (688289) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥122.80 Million (operating CF CN¥59.72 Million minus capex CN¥63.08 Million) represents 0% of total liabilities (CN¥2.24 Billion). Check how resilient are Sansure Biotech Inc's assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sansure Biotech Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Sansure Biotech Inc across 8 annual periods. See Sansure Biotech Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sansure Biotech Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Sansure Biotech Inc. For the full company profile including market capitalisation, see Sansure Biotech Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | CN¥695.55 Million | CN¥274.45 Million | CN¥1.26 Billion | ▲ +12.9% |
| 2023 | 0.49x | CN¥504.17 Million | CN¥112.82 Million | CN¥1.03 Billion | ▼ -73.9% |
| 2022 | 1.88x | CN¥3.12 Billion | CN¥2.56 Billion | CN¥1.66 Billion | ▼ -40.8% |
| 2021 | 3.17x | CN¥2.25 Billion | CN¥1.88 Billion | CN¥709.03 Million | ▼ -18.2% |
| 2020 | 3.88x | CN¥2.75 Billion | CN¥2.64 Billion | CN¥708.95 Million | ▲ +483.2% |
| 2019 | 0.67x | CN¥56.55 Million | CN¥22.41 Million | CN¥84.99 Million | ▲ +141.2% |
| 2018 | 0.28x | CN¥42.97 Million | CN¥10.07 Million | CN¥155.76 Million | ▲ +226.3% |
| 2017 | -0.22x | CN¥-40.76 Million | CN¥-61.44 Million | CN¥186.62 Million | — |